2026 Bio Asia Taiwan
BIO Asia-Taiwan 2026 will officially take place on July 16, 2026, at the 4th floor of Taipei Nangang Exhibition Center, Hall 1.
Xantho Biotechnology will jointly exhibit and share a booth with the Development Center for Biotechnology (DCB) at Booth M434. We warmly welcome you to visit us at the exhibition.
Through this annual industry event, we look forward to continuing to share the results of our Phase I/IIa clinical trial for atopic dermatitis with biotechnology and pharmaceutical companies from Taiwan and around the world.
Looking ahead, in addition to advancing the Phase IIb clinical development, we plan to expand the development of GM-XANTHO® into a new indication for the rare disease pachyonychia congenita(PC), further broadening its therapeutic applications and commercial potential.
Disclaimer
This article and related information on this site contain forward-looking statements. The forward-looking information requires the Company to make numerous assumptions and is subject to inherent risks, uncertainties, and other factors that are beyond the control of the Company which may cause actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. The Company undertakes no obligation to timely inform, update, or revise the information on this site if circumstances should change.
